In vitro study on the antimicrobial activity of various antibiotics against clinical isolates of Streptococcus pneumoniae from Belgium collected during winter 1998-1999

被引:0
|
作者
Vanhoof, R [1 ]
Carpentier, M [1 ]
Fagnart, O [1 ]
Garrino, MG [1 ]
Glupczynski, Y [1 ]
Gordts, B [1 ]
Govaerts, P [1 ]
Magerman, K [1 ]
Mans, Y [1 ]
Nyssen, HJ [1 ]
Surmont, I [1 ]
Schwam, V [1 ]
Van De Vyvere, MV [1 ]
Van Landuyt, H [1 ]
Van Nimmen, L [1 ]
Van Noyen, R [1 ]
机构
[1] Pasteur Inst Brussel, Eenheid Antibiot Onderzoek, B-1180 Brussels, Belgium
来源
ACTA CLINICA BELGICA | 2000年 / 55卷 / 06期
关键词
S; pneumoniae; resistance; surveillance;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A total of 205 isolates of Streptococcus pneumoniae obtained from 10 different centres were included in this study. The susceptibilities to penicillin ampicillin, amoxicillin, amoxicillin/clavulanic acid, cefaclor, cefuroxime, cefotaxime, imipenem, ciprofloxacin, gemifloxacin, grepafloxacin, levofloxacin, trovafloxacin, erythromycin, clarithromycin, miocamycin, clindamycin and tetracycline were determined by a microdilution technique following NCCLS recommendations. Decreased susceptibility to penicillin was 16.1% [6.8% intermediate (0.12 - 1 mug/mL) and 9.3% high-level (greater than or equal to2 mug/mL)], cefotaxime insusceptibility (greater than or equal to1 mug/mL) 12.7 %, ciprofloxacine insusceptibilty (greater than or equal to2 mug/mL) 15.6 % with 1.5 % of high level resistance (greater than or equal to4 mug/mL), erythromycin insusceptibility (greater than or equal to0.5 mug/mL) 36.1 % and tetracycline insusceptibility (greater than or equal to4 mug/mL) 22.9 %. Decreased susceptibility to cefotaxime was found in 78.8 % of the penicillin-insusceptible isolates. No decreased susceptibility was found for gemifloxacin (greater than or equal to0.5 mug/mL) and trovafloxacin (greater than or equal to1 mug/mL). Compared to the 1996-1997 surveillance, penicillin, cefotaxime and erythromycin insusceptibility rose by 3.8 %, 5.2 % and 5.0 % respectively, while tetracycline insusceptibility decreased with 8.2 %. MICs of all beta -lactams rose with those of penicillin for penicillin-insusceptible isolates. Amoxicillin +/- cravulanate, cefotaxime and imipenem were generally 1, 1 and 5 doubling dilutions respectively more potent than penicillin on these isolates. Penicillin, ampicillin and cefuroxime were equally active while cefaclor was generally 5 dilutions less potent. Most penicillin-insusceptible isolates remained fully susceptible to amoxicillin +/- clavulanate and imipenem. The penicillin-insusceptible isolates were 36.4 %, 27.3 % and 3.0 % co-insusceptible to erythromycin, erythromycin plus tetracycline and tetracycline respectively. A subpopulation of 52 isolates obtained from children aged less than or equal to 3 years was also studied. Compared to the other isolates we found a statistically significant increase in insusceptibility for penicillin, cefaclor, cefuroxime, erythromycin, clarithromycin and tetracycline while a significant decrease was found for ciprofloxacin.
引用
收藏
页码:312 / 322
页数:11
相关论文
共 50 条
  • [1] The activity of Levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000
    Jones, ME
    Blosser-Middleton, RS
    Critchley, IA
    Thornsberry, C
    Sahm, DF
    Yamakita, J
    Akasaki, M
    Karlowsky, JA
    [J]. CHEMOTHERAPY, 2002, 48 (05) : 232 - 237
  • [2] Surveillance of antibiotic resistance in clinical isolates of streptococcus pneumoniae collected in Belgium during winter 2000-2001
    Vanhoof, R
    Carpentier, M
    Cartuyvels, R
    Damée, S
    Fagnart, O
    Garrino, MG
    Glupczynski, Y
    Gordts, B
    Govaerts, D
    Magerman, K
    Mans, I
    Surmont, I
    Van Bossuyt, E
    Van De Vyvere, M
    Van Landuyt, H
    Van Nimmen, L
    Van Noyen, R
    [J]. ACTA CLINICA BELGICA, 2003, 58 (02): : 111 - 119
  • [3] In Vitro Antimicrobial Activity of Cefditoren against Streptococcus pneumoniae and Haemophilus influenzae Clinical Isolates
    Kim, Nam Joong
    Kim, Sung Hye
    Kim, Mi Young
    Jun, Jae Bum
    Park, Su Jin
    Kwak, Yee Gyung
    Jeong, Jin-Yong
    Choi, Sang-Ho
    Woo, Jun Hee
    Ryu, Jiso
    Kim, Yang Soo
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S83 - S83
  • [4] The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002
    Jones, ME
    Blosser-Middleton, RS
    Thornsberry, C
    Karlowsky, JA
    Sahm, DF
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 47 (04) : 579 - 586
  • [5] 10th Survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007-2008
    Vanhoof, R.
    Camps, K.
    Carpentier, M.
    De Craeye, S.
    Frans, J.
    Glupczynski, Y.
    Goffinet, P.
    Gordts, B.
    Govaerts, D.
    Ide, L.
    Lefevre, P.
    Lontie, M.
    Cartuyvels, R.
    Meunier, F.
    Mulongo, B.
    Philippart, I.
    Surmont, I.
    Van Bossuyt, E.
    Van Eldere, J.
    Verhaegen, J.
    [J]. PATHOLOGIE BIOLOGIE, 2010, 58 (02): : 147 - 151
  • [6] High prevalence of penicillin resistance and comparative in vitro activity of various antibiotics in clinical isolates of Streptococcus pneumoniae isolated in the Province of Hainaut during winter 2004
    Vanhoof, R
    Brouillard, J
    Damée, S
    d'Hondt, N
    Haccourt, A
    Mansoor, I
    Marchal, JF
    Philippart, I
    Trigaux, F
    Van Bosterhaut, B
    Rossi, C
    Van Bossuyt, E
    [J]. ACTA CLINICA BELGICA, 2005, 60 (06): : 345 - 349
  • [7] Survey of antibiotic resistance in non-invasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2006
    Vanhoof, R.
    Van Eldere, J.
    Verhaegen, J.
    [J]. ACTA CLINICA BELGICA, 2007, 62 (06): : 448 - 448
  • [8] Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999
    Mühlemann, K
    Matter, HC
    Täuber, MG
    Bodmer, T
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (04): : 589 - 596
  • [9] In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium
    Verhaegen, J
    Verbist, L
    [J]. ACTA CLINICA BELGICA, 2001, 56 (06): : 349 - 353
  • [10] Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000
    White, RL
    Enzweiler, KA
    Friedrich, LV
    Wagner, D
    Hoban, D
    Bosso, JA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (03) : 207 - 217